腦瞳憫

Home
Photo of Thomas Sch繹n

Thomas Schön

Professor

My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.

News

Toomas Timpka.

No association between COVID-vaccine and decrease in childbirth

COVID-19 vaccination is not the cause behind a decrease in childbirth, according to a study from 腦瞳憫. The results speak against rumours about vaccination and reduced fertility.
vaccination.

SEK 15 million for research into Covid-19 vaccination

A research project coordinated by LiU has been awarded more than SEK 15 million by the Swedish Research Council to evaluate vaccination against Covid-19.

Publications

Latest publications in LiU DiVA

2026

Zerubabel Desita, Temesgen Tadesse, Anders solitander Bohlbro, Armando Sifna, Hikma Fekadu, Segenet Bizuneh, Sruti Sridhar, Dennis Robert, Manoj Tadepalli, Christian Wejse, Thomas Schön, Frauke Rudolf (2026) MAYO CLINIC PROCEEDINGS: DIGITAL HEALTH, Vol. 4, Article 100338 (Article in journal)
Katarina Niward, Clara Braian, Gustav Svärdhagen, Daniel Augustinsson, Isabelle Öhrnberg, Rovina Ruslami, Stellah Mpagama, Elin M. Svensson, Judith Bruchfeld, Jan-Willem Alffenaar, Thomas Schön (2026) Clinical Infectious Diseases, Article PMID 9203213 (Article, review/survey)

2025

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders, Robin M. Warren, Lavania Joseph, Dumisani Ngcamu, Thabisile Gwala, Shaheed V. Omar, Jens Vereecken, Bouke C. de Jong, Leen Rigouts, Emanuele Borroni, Daniela M. Cirillo, Thomas Schön, Paolo Miotto, Claudio U. Koser (2025) Antimicrobial Agents and Chemotherapy (Article in journal)
Thomas Schön, Paolo Miotto, Varvara K. Kozyreva, Matthew D. Sylvester, Daniela M. Cirillo, Claudio U. Koser (2025) Antimicrobial Agents and Chemotherapy (Article in journal)
Trinh Thi Trang Nhung, Swati Verma, Saravanaraman Ponne, Gautam Kumar Meghwanshi, Thomas Schön, Rajender Kumar (2025) Computational and Structural Biotechnology Journal, Vol. 27, p. 2924-2932 (Article, review/survey)

Research

A doctor looks at X-rays.

Individualised diagnosis and treatment of tuberculosis

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

Organisation

Teaser image for the division II at BKV.

Division of Inflammation and Infection (II)

The Division of Inflammation and Infection (II) includes clinical subject areas such as Immunology, Rheumatology, Pathology and Microbiology.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags